ALSO IN THIS MONTH'S ISSUE

More from this month's issue

BEYOND THE PRINTED PAGE

  • A Woman Leader On The Subject Of Women As Leaders
    A Woman Leader On The Subject Of Women As Leaders

    Can women leaders be responsible and liked – at the same time? Sophie Kornowski-Bonnet, head of Roche partnering, discusses her approach to overcoming adversity, leading to an interesting discussion on if there are differences beyond gender for male versus female executives.

  • The Intriguing Career Path Of Roche’s Head Of Partnering
    The Intriguing Career Path Of Roche’s Head Of Partnering

    What’s it take to get to the c-suite of a biopharmaceuticals company? For Sophie Kornowski-Bonnet, it was a willingness to step out of her comfort zone. The current head of Roche partnering and executive committee member, shares her intriguing career path, which began in Paris, France, back in 1986.

  • Daniel Skovronsky – From Grad Student, To CEO, To Big Pharma
    Daniel Skovronsky – From Grad Student, To CEO, To Big Pharma

    Prior to joining Lilly as SVP of clinical and product development, Daniel Skovronsky, M.D., Ph.D. was CEO of Avid Radiopharmaceuticals — a company he founded while still a graduate student. This article is a prequel to the upcoming feature in our November issue that explores how he built a $300 million company.

  • Does The Biopharmaceutical Industry Need To Broaden Its Horizons?
    Does The Biopharmaceutical Industry Need To Broaden Its Horizons?

    When I interviewed Axovant Sciences CEO David Hung, one of the questions posed was sparked by our discussion of his experience at Pro-Duct Health and his invention of a microcatheter for early detection of ductal breast cancer in women. As he explained his medical device invention, Hung commented, “I don’t want to be just medicines, or just devices, or anything like that.”

More beyond the printed page articles

WEB-EXCLUSIVE EDITORIAL

  • Stand And Deliver: Practical Steps To Stop Antibiotic Resistance
    Stand And Deliver: Practical Steps To Stop Antibiotic Resistance

    For antibiotics, we need more investments in basic science, drug discovery, and clinical development. The big risk now is that the market for new antibiotics is absent as any incentive to invest in new medicines fades when their sole purpose would be to be used only exceptionally.

  • An Industry On The Brink Of Radical Reinvention
    An Industry On The Brink Of Radical Reinvention

    Accenture’s 2017 Technology Vision for Life Sciences examines how major technology trends are shaping the industry and provides recommendations for life sciences companies on how best to take advantage. Across the five trends we uncovered, the unifying theme was how technology is empowering patients and consumers, while driving business results:

  • Three Steps to a More Resilient Organization
    Three Steps to a More Resilient Organization

    Your leadership is the key to keeping your workforce focused, productive, optimistic, and creative no matter what comes your way. Here are three keys to building resilience in today’s dynamic healthcare universe.

  • End Of A Humira Battle: Observations From The AbbVie-Amgen Armistice
    End Of A Humira Battle: Observations From The AbbVie-Amgen Armistice

    The recent settlement of the patent war involving Amgen’s biosimilar to AbbVie’s Humira (adalimumab) has caused rippling in the pharmaceutical industry. The companies had been battling worldwide since at least as early as August 2016, when AbbVie filed a lawsuit against Amgen in the U.S. District Court for the District of Delaware.

  • Rare Diseases Require Unique Approaches In Clinical Trial Design
    Rare Diseases Require Unique Approaches In Clinical Trial Design

    The vast majority of rare diseases have no approved treatments available, despite the fact that research related to these diseases has expanded significantly in the past 20 years. A key reason may be the many unique challenges researchers face when developing drugs to treat rare diseases, including difficulties designing and executing effective and appropriate clinical trials.

  • Are These 3 Fear Factors Holding You Back From Regulatory Compliance?
    Are These 3 Fear Factors Holding You Back From Regulatory Compliance?

    In the TV series Fear Factor, contestants had to overcome various challenges that most of us found disgusting and/or frightening in order to win a large cash prize. If they failed, their hopes were gone and the contest ended for them. The same can be true for the pharmaceutical industry in trying to achieve the “prize” of being found compliant when audited.

  • FDA Draft Guidance On Electronic Records And Signatures: The Next Chapter
    FDA Draft Guidance On Electronic Records And Signatures: The Next Chapter

    The FDA has released a Draft Guidance titled Use of Electronic Records and Electronic Signatures in Clinical Investigations Under 21 CFR Part 11 – Questions and Answers. Certainly, the development of this draft guidance was driven by the repetitious questions the FDA has received from industry stakeholders as well as the extensive technology advancements.

  • How Amazon Could Disrupt The CRO Model
    How Amazon Could Disrupt The CRO Model

    Based on Amazon's approach to building its business, it is logical to conclude that the online retailer would be an amazing CRO. Amazon’s competitive strategy is to aggressively discount prices to win market share. Plus, its customer obsession and disruptive innovation are second to none. Let’s imagine what an Amazon-run CRO would look like.

More web-exclusive editorial

LIFE SCIENCE TRAINING INSTITUTE COURSES

Implementing the ASTM E2500 Validation Method: 10 Years of Key Learnings November 28, 2017
1pm-2:30pm EST, Online Training
The Top Method Validation Mistakes – And How to Avoid Them November 29, 2017
1pm-2:30pm EST, Online Training
An Introduction to Good Laboratory Practices (GLP) December 5, 2017
1pm-2:30pm EDT, Online Training
Auditing Validated Computer Systems In A GxP Environment December 12, 2017
1pm-2:30pm EST, Online Training
More training courses

NOVEMBER 2017 DIGITAL EDITION

2017 CMO & CRO AWARDS EDITIONS

   

@LIFESCILEADER1

 EVENTS

Implementing the ASTM E2500 Validation Method: 10 Years of Key Learnings November 28, 2017
1pm-2:30pm EST, Online Training)
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
The Top Method Validation Mistakes – And How to Avoid Them November 29, 2017
1pm-2:30pm EST, Online Training)
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
An Introduction to Good Laboratory Practices (GLP) December 5, 2017
1pm-2:30pm EDT, Online Training)
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
Data Integrity: Why Not Identifying Repeat Defects In Your Data Is Killing Your Performance December 7, 2017
1:00 PM - 2:00 PM EDT)
Duration:  60 Minutes
Price:  $299 – Includes Bonus handouts
Auditing Validated Computer Systems In A GxP Environment December 12, 2017
1pm-2:30pm EST, Online Training)
Duration:  90 Minutes
More events....